Illumina Body Map 2 (GSE30611)
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
OTX1 | hg38_v1_chr2_+_63050813_63050839 | -0.41 | 2.1e-02 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr7_-_15686671 Show fit | 2.54 |
ENST00000262041.6
|
mesenchyme homeobox 2 |
|
chr14_-_106675544 Show fit | 2.52 |
ENST00000390632.2
|
immunoglobulin heavy variable 3-66 |
|
chr9_+_98943705 Show fit | 2.10 |
ENST00000610452.1
|
collagen type XV alpha 1 chain |
|
chr3_+_188947199 Show fit | 1.48 |
ENST00000433971.5
|
tumor protein p63 regulated 1 |
|
chr1_-_91886144 Show fit | 1.40 |
ENST00000212355.9
|
transforming growth factor beta receptor 3 |
|
chr21_+_32298945 Show fit | 1.35 |
ENST00000339944.4
|
melanocortin 2 receptor accessory protein |
|
chr19_-_47113756 Show fit | 1.30 |
ENST00000253048.10
|
zinc finger CCCH-type containing 4 |
|
chr4_-_137532452 Show fit | 1.30 |
ENST00000412923.6
ENST00000511115.5 ENST00000344876.9 ENST00000507846.5 ENST00000510305.5 ENST00000611581.1 |
protocadherin 18 |
|
chr9_+_122370523 Show fit | 1.27 |
ENST00000643810.1
ENST00000540753.6 |
prostaglandin-endoperoxide synthase 1 |
|
chr7_+_121062765 Show fit | 1.23 |
ENST00000423795.5
|
cadherin like and PC-esterase domain containing 1 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 6.5 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
0.4 | 3.1 | GO:0070171 | negative regulation of tooth mineralization(GO:0070171) |
0.4 | 2.5 | GO:0001757 | somite specification(GO:0001757) |
0.2 | 2.2 | GO:0002778 | antimicrobial peptide production(GO:0002775) antibacterial peptide production(GO:0002778) |
0.0 | 2.2 | GO:0002181 | cytoplasmic translation(GO:0002181) |
0.0 | 1.9 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.3 | 1.4 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.0 | 1.4 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.1 | 1.3 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
0.3 | 1.2 | GO:0090119 | vesicle-mediated cholesterol transport(GO:0090119) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 6.5 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
0.1 | 2.1 | GO:0098651 | basement membrane collagen trimer(GO:0098651) |
0.0 | 1.6 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.0 | 1.6 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.2 | 1.4 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.0 | 1.2 | GO:0032982 | myosin filament(GO:0032982) |
0.1 | 0.9 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.0 | 0.9 | GO:0005922 | connexon complex(GO:0005922) |
0.0 | 0.8 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.0 | 0.6 | GO:0034464 | BBSome(GO:0034464) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 6.5 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.0 | 3.3 | GO:0005518 | collagen binding(GO:0005518) |
0.0 | 3.2 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.0 | 2.5 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.0 | 2.1 | GO:0016811 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides(GO:0016811) |
0.5 | 1.4 | GO:0070123 | transforming growth factor beta receptor activity, type III(GO:0070123) |
0.5 | 1.4 | GO:0031780 | corticotropin hormone receptor binding(GO:0031780) type 5 melanocortin receptor binding(GO:0031783) |
0.3 | 1.4 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.3 | 1.3 | GO:0004666 | prostaglandin-endoperoxide synthase activity(GO:0004666) |
0.2 | 1.2 | GO:0047374 | methylumbelliferyl-acetate deacetylase activity(GO:0047374) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 3.1 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.0 | 2.8 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.0 | 2.4 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.0 | 1.9 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.0 | 1.5 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.0 | 1.3 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.0 | 1.2 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.0 | 0.9 | PID BARD1 PATHWAY | BARD1 signaling events |
0.0 | 0.9 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.0 | 0.8 | PID MYC PATHWAY | C-MYC pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 3.2 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.1 | 2.1 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.0 | 1.9 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.0 | 1.2 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.0 | 1.0 | REACTOME KINESINS | Genes involved in Kinesins |
0.0 | 0.9 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.0 | 0.9 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.0 | 0.9 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.0 | 0.8 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.0 | 0.8 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |